For the past couple of years I have been hearing that CryoPort (OTCBB: CYRX) is not a "real" company because they don't have significant revenues. Well to those people I would say that no R&D company has significant revenues ... its part of being an R&D company. But those doubters can no longer (at least with an ounce of credibility) say that CryoPort is not the real deal.
Today's news on CryoPort validates a lot of what has been discussed about this company over the past couple of years. The primary issue facing CYRX is getting the story in front of people. I am not quite sure what CarpeDM is actually doing. I am fairly confident that they are not an IR firm and they don't seem to be much of a PR firm either. Anyone in this business should absolutely know that this type of news needs to include trading symbols in the release. Today it was Federal Express (NYSE: FDX) that was not included and it is the same problem that we had last week with the Quest Diagnostics (NYSE: DGX) release.
April 21, 2008: Federal Express Release
April 17, 2008: Quest Diagnostics Release
Here is the rub. Let's say that there are 500 people that are currently watching CryoPort very closely. They buy when the stock price dips, they read the news, etc. etc. When news like these 2 releases becomes public, this information needs to be in front of A LOT of investors, both retail and institutional. However, by only including the CYRX trading symbol in the releases, no new investors are hearing about the company. It is only being discussed by the investors who already know about the stock, and most of them already own it. Had the ticker symbols for FedEx and Quest been included into the last two releases, CYRX would have been in front of hundreds of thousands, if not millions, of new investors. When good news on a lightly followed stock is seen by hundreds of thousands of new investors, the typical follow through is NOT what we saw over the last couple of days.
Why is this so hard to figure out? An investor who communicates with me regularly recently contacted Stuart Fine at CarpeDM and was told that the newswires are the ones to call and confirm whether it is okay to include another company's symbol in the release and he didn't want to delay the news because they weren't sure how long it might take to get an answer.
First, the newswires only call if the other company's ticker symbol is actually put in the release when it is submitted. Second, if you don't ask for permission to include their trading symbol in the release that they have already approved, you can be assured that you are not going to get it. Rest assured that FedEx and Quest approved their company's name to be included in the headline of the release. As such, I seriously doubt they would object to including the ticker symbol in the body. This news is positive news for their companies (FedEx & Quest) and every public company likes positive press.
Note to Stuart Fine ... Unless you have a better way to get 1,000,000 new investors to read your press releases, how about let's at least ask if we can put the ticker in there. I don't care if it takes an extra week to get the approval, the type of exposure that the last two releases could have generated can simply not be purchased through promotional campaigns or marketing of any kind or any budget.
Okay, enough of that. Here is the facts that we know. They are partnered up with FedEx. They are shipping samples all over the globe for Quest Diagnostics. I have discussed that there has been a world class manufacturer at play here for a long time (going on 2 years now) and they want to get a piece in a big way - a million square feet facility. Does anyone think that this manufacturer is going to drop a couple hundred million to ramp up a facility of this size if there is not going to be a HUGE amount of volume being demanded?
When CryoPort will finalize that deal, I am not sure. I can tell you this though, I own a lot of stock and I am NOT SELLING A SINGLE SHARE.
You want to own "the next Microsoft" ... well, here is your chance. All of the forces that are out there are trying to keep this company out of the spotlight ... in a short time, they won't be able to.
DISCLOSURE: I worked with CryoPort from late 2004 thru August 2007. I assisted them in the process of becoming a public company in 2005 and I am pretty comfortable with the story. On my private equity side, both my clients, and myself personally, own stock in CryoPort and I also personally own some warrants. For the record, I am not consulting to them at this time and have not personally spoken with anyone in management about the status or operations of the company since the fall of 2007.
